Conley Chee serves as Executive at Syros Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Conley Chee has executed 9 insider transactions totaling $161.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 11, 2024 involved purchasing 50,000 shares valued at $85.5K.
Conley Chee currently holds 122,504 shares of Syros Pharmaceuticals, Inc. (SYRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Conley Chee has been a net buyer of SYRS stock. They have purchased $161.0K and sold $0 worth of shares.
Conley Chee's most recent insider trade was on Sep 11, 2024, when they purchased 50,000 shares at $1.71 per share.
Get notified when new Form 4 filings are submitted
| $1.51 |
| Discretionary |
| Apr 1, 2024 | SYRS | $17.9K | Payment | 3,500 | $5.12 | Discretionary |
| Mar 31, 2024 | SYRS | $0 | Option Exercise | 11,666 | $N/A | Discretionary |
| Mar 31, 2024 | SYRS | $0 | Option Exercise | 2,000 | $N/A | Discretionary |
| Nov 1, 2023 | SYRS | $13.3K | Payment | 6,004 | $2.22 | Discretionary |
| Oct 31, 2023 | SYRS | $0 | Option Exercise | 17,000 | $N/A | Discretionary |
| Apr 3, 2023 | SYRS | $1.7K | Payment | 658 | $2.58 | Discretionary |
| Mar 31, 2023 | SYRS | $0 | Option Exercise | 2,000 | $N/A | Discretionary |